UroGen Pharma Cash Flow Statement (2017-2026) | URGN

Cash Flow Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-26.22M-30.21M-1.85M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-27.80M-32.29M-33.40M-23.67M-6.15M-43.84M-49.94M-33.35M-26.46M-23.57M
Share-based Compensation (Quarter)
6.05M5.51M5.36M2.95M2.82M2.44M2.37M2.29M2.22M2.22M2.61M2.76M3.56M3.49M3.30M3.07M18.30M17.60M3.13M4.63M
Asset Writedowns and Impairment (Quarter)
0.35M0.26M
Cash from Operations (Quarter)
-18.95M-18.48M-20.07M-24.00M-24.20M-17.61M-21.75M-25.81M-20.27M-17.30M-13.00M-31.73M-23.75M-27.66M-13.62M-42.02M-39.83M-42.27M-38.33M-45.32M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.01M0.18M-0.48M0.28M-0.45M1.25M0.68M0.35M0.31M0.32M0.05M0.18M0.30M1.07M1.34M0.77M1.03M-1.32M1.97M
Amortization of Deferred Charges (Quarter)
0.23M0.23M0.24M0.24M0.24M0.20M0.21M0.22M0.22M0.23M0.23M0.23M0.19M0.20M0.24M0.42M0.52M0.56M0.60M0.58M
Depreciation & Amortization (CF) (Quarter)
0.20M0.20M0.21M0.20M0.20M0.20M0.20M0.22M0.20M0.20M0.19M0.10M0.10M0.10M0.07M0.10M0.10M0.10M0.07M0.10M
Change in Working Capital
Change in Receivables (Quarter)
3.21M-1.73M3.93M-2.22M2.10M-2.17M3.27M-0.21M3.01M-2.66M2.60M-1.28M3.26M5.39M-2.50M-0.66M0.01M0.05M13.38M22.33M
Change in Inventory (Quarter)
0.09M0.39M1.02M-0.08M0.56M0.17M-0.28M1.14M-0.48M0.01M0.67M1.57M0.20M0.15M1.63M-1.64M-0.46M1.21M8.12M4.46M
Change in Accured Expenses (Quarter)
-3.32M-0.30M5.08M0.30M-0.82M-2.23M2.04M-3.34M1.80M3.24M0.86M-5.83M13.04M-7.22M-0.24M-3.60M4.68M-1.28M-0.00M7.63M
Other Working Capital Changes (Quarter)
-1.01M0.81M1.36M1.80M1.16M0.15M0.52M1.04M0.58M3.31M-5.76M0.21M1.72M1.84M-5.21M4.14M-0.93M0.07M2.55M4.86M
Investing Activities
Capital Expenditures (Quarter)
0.74M-0.48M0.47M0.03M0.06M0.15M0.01M0.02M0.01M-0.73M-0.01M0.08M-1.75M0.22M-0.22M0.43M5.96M-1.60M0.05M
Change in Acquisitions & Divestments (Quarter)
10.98M18.33M9.63M13.62M-0.09M27.67M23.12M30.47M3.73M11.33M3.54M13.52M12.08M12.14M69.97M40.43M30.34M40.21M28.27M4.15M
Cash from Investing Activities (Quarter)
-30.74M10.66M9.12M13.60M-0.15M-35.49M23.11M6.27M3.72M0.40M-11.34M13.52M12.00M-106.75M60.62M-25.96M28.41M31.40M27.72M-20.69M
Financing Activities
Other financing activities (Quarter)
0.05M0.00M0.02M1.12M0.38M0.67M0.14M47.89M-47.83M0.14M18.51M0.03M-0.03M-0.00M0.18M
Cash from Financing Activities (Quarter)
72.52M-0.17M-0.03M70.74M-0.08M1.10M25.37M0.67M0.14M116.08M0.04M54.66M100.28M39.61M0.07M0.03M0.30M8.27M31.32M65.20M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
67.36M56.10M80.07M15.00M0.00M-0.00M8.20M31.83M
Additional items
Change in Cash (Quarter)
22.83M-7.98M-10.98M60.34M-24.43M-52.00M26.72M-18.87M-16.41M99.18M-24.30M36.44M88.53M-94.81M47.07M-67.95M-11.12M-2.60M20.71M-0.80M
Free Cash Flow (Quarter)
-19.68M-18.00M-20.54M-24.02M-24.26M-17.77M-21.77M-25.83M-20.29M-16.57M-12.98M-31.73M-23.83M-25.91M-13.84M-41.81M-40.26M-48.23M-36.73M-45.37M
Net Cash Flow (Quarter)
22.83M-7.98M-10.98M60.34M-24.43M-52.00M26.72M-18.87M-16.41M99.18M-24.30M36.44M88.53M-94.81M47.07M-67.95M-11.12M-2.60M20.71M-0.80M